Arkolith/Insider Trading/ITOS/Form 4

Hallal David

DirectoriTeos Therapeutics, Inc. (ITOS) · full profile →Form 4 · filed Jun 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 6, 2025Option exercise(M)38K$4.30$164K38K
Jun 6, 2025Sell(S)38K$10.24$391K0
Jun 5, 2025Option exercise(M)38K$4.30$164K38K
Jun 5, 2025Sell(S)38K$10.15$388K0
Jun 4, 2025Option exercise(M)38K$4.30$164K38K
Jun 4, 2025Sell(S)38K$10.07$385K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 6, 2025Option exercise(M)38K—$00
Jun 5, 2025Option exercise(M)38K—$038K
Jun 4, 2025Option exercise(M)38K—$076K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-083410) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML